[go: up one dir, main page]

MX2022002730A - Composiciones que contienen trifosfato de adenosina (atp) y metodos de uso. - Google Patents

Composiciones que contienen trifosfato de adenosina (atp) y metodos de uso.

Info

Publication number
MX2022002730A
MX2022002730A MX2022002730A MX2022002730A MX2022002730A MX 2022002730 A MX2022002730 A MX 2022002730A MX 2022002730 A MX2022002730 A MX 2022002730A MX 2022002730 A MX2022002730 A MX 2022002730A MX 2022002730 A MX2022002730 A MX 2022002730A
Authority
MX
Mexico
Prior art keywords
atp
methods
adenosine triphosphate
compositions containing
containing adenosine
Prior art date
Application number
MX2022002730A
Other languages
English (en)
Inventor
John Rathmacher
Naji Abumrad
Shawn Baier
Lisa Pitchford
Larry Kolb
Matthew Legge
Original Assignee
Tsi Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsi Group Co Ltd filed Critical Tsi Group Co Ltd
Publication of MX2022002730A publication Critical patent/MX2022002730A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A23L29/04—Fatty acids or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención proporciona una composición que comprende adenosina o trifosfato de adenosina (ATP) que actúa como un aumentador de absorción cuando se combina con un material(es) nutricional tales como nutrientes, proteína, péptidos, vitaminas, fitoquímicos, minerales, ácidos grasos o aminoácidos o un fármaco. Se describen métodos para administrar ATP o adenosina para mejorar la biodisponibilidad de un material(es) nutricional tales como nutrientes, proteína, péptidos, vitaminas, fitoquímicos, minerales, ácidos grasos o aminoácidos o un fármaco.
MX2022002730A 2019-09-05 2020-09-04 Composiciones que contienen trifosfato de adenosina (atp) y metodos de uso. MX2022002730A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962896335P 2019-09-05 2019-09-05
US201962939986P 2019-11-25 2019-11-25
PCT/US2020/049417 WO2021046357A1 (en) 2019-09-05 2020-09-04 Compositions containing adenosine triphosphate (atp) and methods of use

Publications (1)

Publication Number Publication Date
MX2022002730A true MX2022002730A (es) 2022-08-19

Family

ID=74850675

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002730A MX2022002730A (es) 2019-09-05 2020-09-04 Composiciones que contienen trifosfato de adenosina (atp) y metodos de uso.

Country Status (13)

Country Link
US (3) US11666593B2 (es)
EP (1) EP4025579B1 (es)
JP (1) JP2022546843A (es)
CN (1) CN115427417A (es)
AU (1) AU2020341578A1 (es)
BR (1) BR112022004108A2 (es)
CA (1) CA3153548A1 (es)
CL (1) CL2022000546A1 (es)
CO (1) CO2022004317A2 (es)
EC (1) ECSP22024879A (es)
MX (1) MX2022002730A (es)
PE (1) PE20230264A1 (es)
WO (1) WO2021046357A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022002730A (es) * 2019-09-05 2022-08-19 Tsi Group Co Ltd Composiciones que contienen trifosfato de adenosina (atp) y metodos de uso.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
US6566371B2 (en) * 2000-04-28 2003-05-20 University Of Pittsburgh Intraperitoneal administration of adenosine for the treatment of prevention of gastrointestinal of systemic diseases
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
WO2005074946A1 (en) 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
EP2374452B1 (en) * 2008-12-05 2019-07-24 Ajinomoto Co., Inc. Nutrient composition
US8703719B1 (en) * 2009-05-18 2014-04-22 Bio-Engineered Supplements And Nutrition, Inc. Method and composition for improved muscle performance
US20110305737A1 (en) * 2010-06-09 2011-12-15 NY Derm LLC Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology
MX2022002730A (es) * 2019-09-05 2022-08-19 Tsi Group Co Ltd Composiciones que contienen trifosfato de adenosina (atp) y metodos de uso.

Also Published As

Publication number Publication date
WO2021046357A1 (en) 2021-03-11
US20250186476A1 (en) 2025-06-12
PE20230264A1 (es) 2023-02-07
US12251393B2 (en) 2025-03-18
CO2022004317A2 (es) 2022-08-30
ECSP22024879A (es) 2022-06-30
US20210069229A1 (en) 2021-03-11
AU2020341578A1 (en) 2022-04-21
JP2022546843A (ja) 2022-11-09
US11666593B2 (en) 2023-06-06
BR112022004108A2 (pt) 2022-05-31
CN115427417A (zh) 2022-12-02
US20230338408A1 (en) 2023-10-26
EP4025579A1 (en) 2022-07-13
CL2022000546A1 (es) 2023-03-17
EP4025579B1 (en) 2025-07-16
CA3153548A1 (en) 2021-03-11
EP4025579A4 (en) 2023-09-27

Similar Documents

Publication Publication Date Title
BR112018071518A2 (pt) compostos medicinais à base de planta de ação rápida e suplementos nutricionais
MX2023002982A (es) Inhibidores de la interaccion de menina-leucemia de linaje mixto.
CY1126062T1 (el) Σταθερη φαρμακοτεχνικη μορφη anti-ifnar1
MX2023001319A (es) Polipeptidos condicionalmente activos.
MX2018009230A (es) Formulaciones nutritivas que comprenden un aislado de proteina de guisante.
EA201892396A1 (ru) Быстродействующие растительные лекарственные соединения и биологически активные добавки
CL2020000897A1 (es) Composición de proteínas de guisante que tiene calidad nutricional mejorada.
NZ743964A (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
CR20180027A (es) Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la misma terapia contra el cáncer epitelial de ovario y otros tipos de cáncer.
MX2019007968A (es) Compuestos medicinales y suplementos nutricionales.
BR112017009405A2 (pt) composições antibióticas.
EA202090889A1 (ru) Травяные композиции с улучшенной биодоступностью
MX2017008815A (es) Composicion que contiene quitina y proteinas digeribles.
AR039170A1 (es) Co-granulos de dha y romero y metodos de uso
BR112022009563A2 (pt) Compostos de pirrolotriazina atuando como inibidor de mnk
BR112023023463A2 (pt) Inibidores da interação menin-mll
CY1124677T1 (el) (1s,4s)-4-(2-(((3s,4r)-3-φθoροtetpaϋδpo-2h-πypan-4-yλ)amino)-8-((2,4,6-τριχλωροφαινυλ)αμινο)-9η-πουριν-9-υλ)-1-μεθυλοκυκλοεξανο-1-καρβοξαμιδιο και μεθοδοι χρησης αυτου
MX2021008022A (es) Proteínas heterodiméricas para modular células t gamma delta.
MX2022002730A (es) Composiciones que contienen trifosfato de adenosina (atp) y metodos de uso.
CL2021003474A1 (es) Producto farmacéutico para terapia enzimática para tratamiento de homocistinuria
CL2023000491A1 (es) Composiciones de erenumab y usos de las mismas (divisional de solicitud n° 02519-2020).
AR098035A1 (es) Composición alimenticia para animales rumiantes que contiene proteínas y método de preparación
CL2019000099A1 (es) Factor vii de coagulación de larga duración y métodos para producir el mismo.
WO2017021974A3 (en) NOVEL SYNERGISTIC COMPOSITION OF LECITHIN AND LYSOLECHINE TO IMPROVE BIOAVAILABILITY AND SOLUBILITY OF HYDROPHOBIC COMPOUNDS AND EXTRACTS
PH12020500452A1 (en) Infant formula having decreased protein content